secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2026-08-17T21:27:41+00:00
Accession:  0001104659-26-097949
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus closes $55M Innovatus term loan, repays prior 8%+SOFR facility due 2029
-------------------------------------------------------------------------------

- Drew full $55M Tranche A on Aug 14, 2026; matures Aug 2031; rate 4.15% + greater of Prime or 6.75%.
- Proceeds repaid prior senior secured facility (8.0% + 3-mo SOFR, due May 2029); remainder for working capital.
- Interest-only for 36 months, extendable to 48 months upon revenue and market-cap milestones.
- Optional tranches: $25M Term B (milestone-gated) and $20M Term C (lender discretion).
- Prepayment fee 5% declining to 0% after year 3; final fee 4% (10% if DIP financing); facility fee 1.5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000110465926097949/0001104659-26-097949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000110465926097949/chrs-20260817x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-097949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer